Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05935956 · ClinicalTrials.gov registry record
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
A clinical trial of Neuropathic Pain and Chemotherapy-induced Peripheral Neuropathy, sponsored by NeuraLace Medical.
- Completed
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT05935956 is a study of Neuropathic Pain and Chemotherapy-induced Peripheral Neuropathy that has completed, run by NeuraLace Medical. The registered enrollment target is 14 participants, below the 101-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05935956, a study of Neuropathic Pain and Chemotherapy-induced Peripheral Neuropathy, has completed, sponsored by NeuraLace Medical.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess the safety and effectiveness of Axon Therapy in the treatment of chemotherapy-induced neuropathy
Conditions Studied
Interventions
- DEVICE Magnetic Peripheral Nerve Stimulation
Study Locations (1)
North Carolina
- Carolinas Pain Institute and Center for Clinical Research - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2023-12-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05935956
The ClinicalTrials.gov registry entry for NCT05935956 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (86% lower). The listed sponsor is NeuraLace Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Neuropathic Pain appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Peripheral Nerve Stimulation is the first listed.
NCT05935956 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05935956 about?
NCT05935956 is a clinical study titled "Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy". Assess the safety and effectiveness of Axon Therapy in the treatment of chemotherapy-induced neuropathy
What is the current status of trial NCT05935956?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2023-06-09. Estimated completion is 2023-12-21.
What conditions does trial NCT05935956 study?
This clinical trial studies the following conditions: Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy, Neuralgia.
What interventions are being tested in trial NCT05935956?
The interventions under investigation include: Magnetic Peripheral Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05935956?
This trial is sponsored by NeuraLace Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05935956 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
RECRUITING · NA
-
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
RECRUITING · Phase 4
-
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
RECRUITING · Phase 1
-
Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study
RECRUITING
-
Diabetic Neuropathy in Spinal Cord Stimulator Patients
RECRUITING
Explore more on PlainTrial
Neuropathic Pain
All registered trials for this condition
Chemotherapy-induced Peripheral Neuropathy
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.